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Although nasal continuous positive airway pressure (CPAP) is effective in improving nocturnal obstructive apnoea,
daytime sleepiness and well-being in patients with obstructive sleep apnoea syndrome (OSAS), not all patients
tolerate this treatment. Since optimal CPAP titration is essential to maintain compliance, it is important to
elucidate the factors that help to determine the optimal pressure. However, the determinants of the optimal CPAP
level are controversial.
The subjects comprised 27 Japanese male patients with OSAS who underwent standard polysomnography (PSG),
pulmonary function tests, arterial blood gas analysis, cephalometry and CPAP titration. Twenty normal controls
also underwent cephalometric analysis.
The apnoea–hypopnoea index (AHI), mean oxygen saturation (mean SaO2) and the lowest SaO2 during sleep
were found to be 54?7+22?6, 89?0+5?6%, and 69?7+9?0%, respectively by PSG. The mean optimal CPAP was
9?6+1?8 cmH2O. The cephalometric angles (SNA, SNB and NSBa) were similar to those found in the control
subjects, but MP-H, and PNS-P were significantly longer than those in the control subjects as shown by
cephalometry. The optimal CPAP was correlated with the mean SaO2 (P50?0001), neck circumference (P50?05)
and three cephalometric variables (NSBa: P50?01, MP-H: P50?05, PNS-P: P50?05). Multiple, step-wise,
regression analysis showed that the mean SaO2 and NSBa were independent variables that best predicted the
optimal CPAP. These variables accounted for 57?5% of the total variance (R2=0?575, P50?001).
Optimal CPAP was closely correlated with oxygen desaturation during sleep. However, the craniofacial structure
had additional effects such as an independent factor in determining the optimal CPAP level.
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Over the past decade, nasal continuous positive airway
pressure (CPAP) has become the first-line of treatment for
obstructive sleep apnoea syndrome (OSAS) (1–3). Although
nasal CPAP is effective in improving nocturnal obstructive
apnoea, daytime sleepiness, cognitive function and well-
being (4–7), not all patients tolerate this treatment (8–16).
Approximately 10–50% of patients with OSAS cannot
tolerate nasal CPAP and discontinue its use within a short
period of time. Although a high level of CPAP abolishes
upper airway obstruction during sleep, patients may feelReceived 31 May 2000 and accepted in revised form 9 February
2001.
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0954-6111/01/050393+05 $35?00/0uncomfortable and may discontinue its use. In addition,
lower pressures may not be sucient to eliminate apnoea or
oxygen desaturation during sleep. Therefore, optimal
titration of CPAP is essential to maintain compliance. It
is important to elucidate the factors that help to determine
the optimal pressure. Hoffstein et al. (17,18) demonstrated
that the number of apnoea and hypopnoea events, body
mass index (BMI) and neck circumference (NC) are closely
correlated with an effective CPAP level. Sforza et al. (19)
reported that the apnoea–hypopnoea index (AHI) is not
correlated with the level of effective CPAP, but that the
bulk of the soft palate and the degree of respiratory efforts
are the primary determinants of the effective CPAP level.
They found a relationship only between the effective CPAP
level and the length of the soft palate.
A number of reports (20–25) demonstrated that patients
with OSAS exhibit craniofacial abnormalities or upper
airway soft tissue changes. However, only one study (19)
examined the relationship between the effective CPAP level# 2001 HARCOURT PUBLISHERS LTD
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Therefore, the aim of this study was to assess the factors
that determine the optimal CPAP level including cephalo-
metric variables in patients with OSAS.
Patients and methods
The subjects comprised 27 Japanese men diagnosed as
having OSAS. All subjects were hospitalized and gave
informed consent to participate in this study. Standard full
night polysomnography (PSG), cephalometry, pulmonary
function tests and arterial blood gas analysis were
performed. PSG was performed in a standard manner
including electroencephalography, electrooculography,
electromyography, electrocardiography, measurements of
oronasal airflow and movement of the rib cage and
abdomen, and oxygen saturation (SaO2). Conventional
spirometry and measurement of static lung volumes were
performed by auto-spirometry (Chestak, Chest Co. Tokyo,
Japan). Arterial blood samples were drawn with the
patients in the supine position and were analysed by an
auto-analyser (ABL 520, Radiometer Co, Tokyo, Japan).
Lateral cephalometric radiography was obtained for all
patients and all 20 control subjects (healthy male volun-
teers, technicians and doctors) while seated in the upright
position using the technique of Riley et al. (20). The
controls were age-matched healthy males without OSA
symptoms such as heavy snoring, excessive daytime
sleepiness, and respiratory abnormalities during sleep.
PSG was not performed in the controls. All radiographs
were taken at the end of expiration without swallowing.
The following variables were measured by two pulmonaryTABLE 1. Anthropometric, pulmonary function and polysomno
Mean
Age (years) 51?5
BMI (kgm72) 28?1
NC (cm) 42?2
VC (% predicted) 110?1
FEV1 (% predicted) 83?7
ERV (ml) 1075?2
FRC (ml) 2461?7
PaO2 (mmHg) 80?2
PaCO2 (mmHg) 44?2
AHI (n h71) 54?7
Arousal index (n h71) 66?8
Total sleep time (min) 384?2
% REM sleep (%) 13?4
% Non-REM sleep (%) 67?2
Mean SaO2 (%) 89?0
Lowest SaO2 (%) 69?7
Optimal CPAP (cmH2O) 9?6
BMI: body mass index; NC: neck circumference; VC: vital capac
reserve volume; FRC: functional residual volume; AHI: ap
continuous positive airway pressure.physicians: (1) SNA [angle measurement from sella (S) to
nasion (N) to point A (subspinale)]; (2) SNB [angle
measurement from sella (S) to nasion (N) to point B
(supramentale)]; (3) NSBa [called cranial base flexure (angle
formed by the intersection of lines drawn from nasium to
sella and sella to basion)]; (4) MP-H [distance from
mandibular plane (MP) to hyoid bone (H)]; (5) PNS-P
[distance from posterior nasal spine (PNS) to the tip of the
soft palate (P)]; and (6) posterior airway space (PAS).
Nasal CPAP titration was performed to determine
the optimal CPAP level with a commercial CPAP device
(7300H, France Bed Med, Tokyo) within 1 week of the first
diagnostic PSG. The optimal level of CPAP was the
minimum pressure that completely abolished apnoea and
snoring and maintained a SaO2490% during sleep. We
confirmed that apnoea and snoring were completely
abolished and SaO2 was maintained at over 90% during
sleep with the optimal CPAP level during the next night.
Results were presented as the mean+SD. Group differ-
ences were assessed with the unpaired t-test. Bivariate
correlation analysis was performed using Pearson correla-
tion coecients. Multiple, step-wise regression analysis was
performed to identify those variables that best explained
the variance in the level of optimal CPAP. Statistical
significance was set at a P-value less than 0?05. All
statistical analyses were performed using a program (Stat-
view) for the PC (Macintosh, version 8?0).
Results
Baseline characteristics of the patients are shown in
Table 1. The mean age, body mass index (BMI) and neckgraphic data
SD Range
9?6 34–66
2?7 17?2–39?4
2?7 35–49
15?2 81?0–146?0
10?4 71?9–114?8
425?3 470–1860
710?7 1470–3870
10?1 62?8–100?2
4?2 36?9–52?6
22?6 13?0–91?0
26?2 21?2–110?4
44?1 280–450
2?6 8?4–24?0
14?8 46?1–81?3
5?6 72?5–95?0
9?0 50?0–86?0
1?8 7?0–14?0
ity; FEV1: forced expiratory volume in 1 sec; ERV: expiratory
noea–hypopnoea index; SaO2: oxygen saturation: CPAP:
equation:
optimal CPAP  42  036ÿ 0  209mean SaO2
ÿ 0  099NSBa:
TABLE 3. Correlation between the optimal CPAP and
baseline characteristics
Correlation coecient (r) P-value
Age 70?296 0?1356
BMI 0?377 0?0524
NC 0?380 0?0499
VC (% predicted) 70?142 0?4847
FEV1 (% predicted) 0?206 0?3052
ERV 70?069 0?7355
FRC 70?157 0?4382
PaO2 70?141 0?4860
PaCO2 0?303 0?1044
AHI 0?074 0?7177
Mean SaO2 70?668 50?0001
Lowest SaO2 70?380 0?0500
SNA 70?271 0?2135
SNB 70?283 0?2373
NSBa 70?532 0?0037
MP-H 0?400 0?0377
PNS-P 0?394 0?0414
PAS 0?229 0?2537
Abbreviations as in Table 1.
TABLE 2. Comparison of age, BMI and cephalometric variables between patients and controls
Patients (n=27) Control (n=20)
Mean SD Range Mean SD Range P
Age (years) 51?5 9?6 34–66 46?4 7?3 35–56 NS
BMI (kgm72) 28?1 4?5 17?2–39?4 24?1 2?8 21–28 50?001
SNA (degrees) 79?8 2?4 76–84 82?0 6?0 69–92 NS
SNB (degrees) 79?3 4?4 70–85 81?1 4?7 71–90 NS
NSBa (degrees) 134?7 8?6 115–155 134?9 8?3 118–154 NS
MP-H (cm) 2?2 0?6 1?0–3?0 1?2 0?6 0?5–2?0 50?001
PNS-P (cm) 4?6 0?7 3?0–6?5 3?6 0?6 2?9–4?5 50?001
PAS (cm) 1?0 0?3 0?5–1?6 1?1 0?3 0?5–1?6 NS
SNA: angle measurement from sella to nasion to subspinale; SNB: angle measurement from sella to nasion to supramentale;
NSBa: cranial base flexure; MP-H: distance from mandibular plane to hyoid bone; PNS-P: distance from posterior nasal spine
to the tip of the soft palate; PAS: posterior airway space.
CPAP IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA 395circumference (NC) were 51?5 years, 28?1 kgm72 and
42?2 cm, respectively. Mean age and BMI of the control
subjects were 46?4+7?3 years and 24?1+2?8 kgm72.
Although the mean age did not significantly differ between
the patients and controls, the mean BMI in the controls was
significantly lower than that of OSAS patients (Table 2).
Pulmonary function tests were almost normal. Although
the mean PaO2 and PaCO2 were within normal limits, four
patients were hypoxaemic (PaO2570 mm Hg) and 13
patients were hypercapnic (PaCO2445mm Hg). PSG
revealed moderate to severe OSAS and oxygen desaturation
during sleep, i.e. an SaO2 less than 75%, was found in 21 of
27 patients. The mean optimal CPAP was 9?6+1?8 cm
H2O.
The results of cephalometry are shown in Table 2. The
angles (SNA, SNB and NSBa) were similar to those found
in control subjects, but MP-H and PNS-P were significantly
longer than those in the control subjects. No significant
relationships were observed between the cephalometric
variables and AHI, the mean SaO2 and the lowest SaO2
during sleep.
Correlation coecients of optimal CPAP were compared
for 18 clinical variables which included anthropometric,
pulmonary function, polysomnographic and cephalometric
data. The results (Table 3) indicated that the optimal CPAP
was significantly correlated with NC (P50?05), nocturnal
oxygen saturation (mean SaO2: P50?0001) and the
parameters of craniofacial structure (NSBa: P50?01, MP-
H: P50?05 and PNS-P: P50?05). The mean SaO2 during
sleep showed the greatest correlation with the optimal
CPAP (r=0?664; Fig. 1). The correlation of pulmonary
function and arterial blood gas data was suciently low
(r50?303) and was not considered a useful predictor of
optimal CPAP. Multiple, step-wise regression analysis of
these 18 variables with optimal CPAP as the dependent
variable showed that the mean SaO2: (partial r
2=0?362)
and NSBa (partial r2=0?213) accounted for 57?5% of the
total variance (r2=0?575, P50?0001) by the followingDiscussion
The results in this study demonstrated that the optimal
CPAP level was dependent on the oxygen desaturation
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FIG. 1. Relationship between optimal CPAP and mean
SaO2.
396 T. AKASHIBA ET AL.during sleep and the craniofacial structure. Oxygen
desaturation (mean SaO2) during sleep was most highly
correlated with optimal CPAP (r=70?664). Although
Miljeteig and Hoffstein (17) investigated the relationship
between effective CPAP levels and anthropometric and
sleep data in patients with OSAS, and found that the AHI,
BMI and neck circumference were correlated with CPAP
levels, they observed no correlation between oxygen
desaturation during sleep and CPAP levels. Sforza et al.
(19) also reported the determinants of effective CPAP levels
in patients with OSAS, and failed to find a correlation
between effective CPAP levels and oxygen desaturation.
This difference may be due to the fact that our subjects
exhibited profound oxygen desaturation during sleep. The
mean SaO2 was lower than that of Miljeteig’s subjects (17)
(88?9% vs. 91%), and the lowest SaO2 in our group was
also lower than that in Sforza’s study (19) (69?6% vs.
81?2%). In addition, we found that 13 of 27 patients with
OSAS were hypercapnic. Ten of 13 patients were con-
sidered to have obesity–hypoventilation syndrome (OHS).
It is reported that these patients had more profound oxygen
desaturation during sleep as well as daytime hypoxaemia
than patients without OHS (26). These differences may
explain the inconsistency between our study and other
studies.
Although oxygen desaturation (mean SaO2) during sleep
was strongly correlated with optimal CPAP, this variable,
by itself, accounted for only 44% of the total variance.
Multiple, step-wise, regression analysis showed that 57?5%
of the total variance was accounted for by the incorpora-
tion of the NSBa into the regression. These data suggest
that the craniofacial structure plays an important role in
determining the optimal CPAP. A number of studies (20–
25) emphasized that patients presenting OSAS exhibited
craniomandibular and upper airway anatomic abnormal-
ities. However, the extent of the contribution of craniofacial
abnormalities to the development of OSAS is unclear. We
found that there were significant differences on craniofacialstructures between the patients and controls (MP-H and
PNS-P). Changes in these parameters, in soft tissue
components, may be induced by repeated snoring and
upper airway obstruction during sleep.
Obesity seems to be more important factor than
craniofacial abnormalities in the development of OSAS in
previous studies. Miljeteig and Hoffstein (17) emphasized
the strong association between body size (BMI and NC)
and the effective CPAP level. We also found a significant
correlation between the optimal CPAP level and the NC
(r=0?380 P=0?0499) and a nearly significant correlation
with BMI (r=0?377 P=0?0524). Therefore, body size likely
plays a substantial role in determining the optimal CPAP.
However, the role of body size may be less important than
the craniofacial structure, since multiple, step-wise regres-
sion showed that oxygen desaturation during sleep and
parameters of craniofacial abnormalities, but not obesity,
were the important independent variables. We also
observed differences in craniofacial structures between the
patients with OSAS and normal subjects although our
control subjects were not matched for BMI. Therefore, it is
likely that craniofacial abnormalities are more important
than obesity in the development of OSAS in our subjects.
Sforza et al. (19) also investigated the relationship between
effective CPAP and cephalometric variables, and found that
effective CPAP was closely correlated with the length of the
soft palate (PNS-P) only. We found that the optimal CPAP
was significantly correlated with PNS-P, NSBa, and MP-H.
These results suggest that Japanese patients with OSAS
have more abnormal craniofacial structures than Western
patients, or it is possible that our findings could be
replicated in any group of near-normal weight patients
with severe OSAS.
We also showed that the mean SaO2 during sleep was
correlated most highly with the optimal CPAP. Since the
mean SaO2 was also correlated with BMI (r=70?680,
P50?001) and NC (r=70?509, P=0?0059), the effect of
body size on optimal CPAP was predominantly exerted
through these relationships. Since there was no significant
correlation between the mean SaO2 and cephalometric
variables, the cranio-base angle (SNBa) showed effects
independent of the mean SaO2 in determining the optimal
CPAP.
Sforza et al. (19) found that the length of the soft palate
as well as respiratory effort during sleep was correlated with
the effective CPAP level. Since we did not measure pleural
pressure to evaluate respiratory effort, we cannot comment
on the contribution of respiratory effort to optimal CPAP.
The use of an oesophageal balloon to measure pleural
pressure is invasive and not practical in predicting the
optimal CPAP.
We did not show a direct relationship between cranio-
facial abnormalities and the development of OSAS because
cephalometric parameters were not significantly associated
with AHI, mean SaO2 and lowest SaO2. However, our
findings that several markers of craniofacial abnormalities
were associated with CPAP levels that protect against
nocturnal upper airway obstruction suggests that cranio-
facial abnormalities are indirectly related to the develop-
ment of OSAS.
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